| 000 | 01820 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518084753.0 | ||
| 264 | 0 | _c20210106 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2020.106288 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Puze | |
| 245 | 0 | 0 |
_aSaikosaponin-d ameliorates dextran sulfate sodium-induced colitis by suppressing NF-κB activation and modulating the gut microbiota in mice. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cApr 2020 |
||
| 300 |
_a106288 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aColitis _xchemically induced |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDextran Sulfate |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 |
_aGastrointestinal Microbiome _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aMucins _xgenetics |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aOleanolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aSaponins _xtherapeutic use |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aWu, Minna | |
| 700 | 1 | _aXiong, Wancheng | |
| 700 | 1 | _aLi, Jinsong | |
| 700 | 1 | _aAn, Yunying | |
| 700 | 1 | _aRen, Jie | |
| 700 | 1 | _aXie, Yingguang | |
| 700 | 1 | _aXue, Hongfei | |
| 700 | 1 | _aYan, Dong | |
| 700 | 1 | _aLi, Min | |
| 700 | 1 | _aZhong, Genshen | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 81 _gp. 106288 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2020.106288 _zAvailable from publisher's website |
| 999 |
_c30638479 _d30638479 |
||